Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results

Last Modified: 9/18/2008 First Published: 5/11/2006


1.		Phase III Randomized Study of Zoledronate in Preventing Osteoporosis and Associated Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiotherapy and Luteinizing Hormone-Releasing Hormone Agonist Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				NCI				RTOG-0518 0518, RTOG-0518, NCT00329797

Last Modified: 9/19/2008 First Published: 8/13/2006


2.		Phase III Randomized Study of Zoledronate, Vitamin D, and Calcium With or Without Strontium Chloride Sr 89 or Samarium Sm 153 Lexidronam Pentasodium in Preventing or Delaying Skeletal-Related Events in Patients With Bone Metastases Secondary to Prostate, Lung, or Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				NCI				RTOG-0517 RTOG 0517, RTOG-0517, NCT00365105


3.		A Study of Actonel for the Prevention of Bone Loss

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Other				ID03-0124 NCT00452439


4.		Chemoprevention of Colorectal Adenomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Active				40 to 75				Pharmaceutical / Industry				COLO CP-01-US NCT00486512

Last Modified: 9/3/2008 First Published: 4/21/2006


5.		Phase II Randomized Study of Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				UMN-2005NT018 UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, NCT00321932

Last Modified: 10/2/2007 First Published: 12/21/2006


6.		Phase II Pilot Study of Vitamin D Deficiency and Myalgias and/or Arthralgias in Postmenopausal Women Receiving Adjuvant Letrozole for Stage I-III Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Natural history/Epidemiology, Supportive care, Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				UWCC-6346 NOVARTIS-UWCC-6346, UWCC-06-2386-H/A, FHCRC-6346, NCT00416715


7.		Effect of Vitamin D and Calcium on Genes in the Colon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention				Active				48 to 72				Other				RUH IRB # PHO-0554 NCT00298545


8.		Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				18 and over				Other				SUNY UMU IRB # 4689 NCT00145704

Last Modified: 7/23/2008 First Published: 5/1/2007


9.		Pilot Randomized Study of Cholecalciferol and Calcium Carbonate in Patients With Resected Colon Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				RPCI-I-78706 NCT00470353

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute